Dr. David Weinstein, M.D.
What this data tells you about Dr. Weinstein
Dr. David Weinstein is an urology physician in Palm Springs, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Weinstein performed 5,840 Medicare services across 3,718 unique beneficiaries.
Between the years covered by Open Payments, Dr. Weinstein received a total of $7,226 from 49 pharmaceutical and/or device companies across 298 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Weinstein is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Florida License Status
FL DOH · MQA| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 57846 | Clear | January 31, 2028 | — |
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Automated urinalysis | 1,500 | $2 | $17 |
| Office visit, established patient (30-39 min) | 1,105 | $98 | $175 |
| Bladder ultrasound after voiding | 954 | $8 | $100 |
| Blood draw (venipuncture) | 256 | $8 | $11 |
| Urine culture, bacterial colony count | 238 | $8 | $35 |
| Urine culture, bacterial identification | 238 | $8 | $35 |
| Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral) | 238 | $7 | $40 |
| New patient office visit (45-59 min) | 188 | $127 | $240 |
| PSA test (prostate cancer screening) | 180 | $18 | $68 |
| Office visit, established patient (20-29 min) | 137 | $70 | $125 |
| Diagnostic exam of bladder and urethra using an endoscope | 114 | $188 | $500 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 99 | $136 | $800 |
| Office visit, established patient, complex (40-54 min) | 90 | $141 | $200 |
| Hospital follow-up visit, moderate complexity | 64 | $66 | $150 |
| Initial hospital admission, high complexity | 59 | $138 | $300 |
| Ultrasound scan of pelvic region through rectum | 56 | $107 | $245 |
| Drug injection, under skin or into muscle | 56 | $11 | $35 |
| Ceftriaxone antibiotic injection | 48 | $0 | $25 |
| Psa (prostate specific antigen) measurement, free | 35 | $18 | $68 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 34 | $25 | $80 |
| Electronic assessment of bladder emptying | 33 | $11 | $225 |
| Complete ultrasound scan behind abdominal cavity | 20 | $50 | $250 |
| Simple bladder irrigation and/or instillation | 19 | $64 | $300 |
| Simple insertion of temporary bladder tube | 19 | $51 | $200 |
| New patient office visit, complex (60-74 min) | 17 | $184 | $300 |
| Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm | 16 | $650 | $2,000 |
| Biopsy of prostate gland | 15 | $198 | $400 |
| Complete laser vaporization of prostate including control of bleeding using an endoscope | 12 | $588 | $2,500 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
3.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Weinstein is a clinical cardiology specialist, with above-average Medicare volume (top 21% in FL), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Weinstein experienced with automated urinalysis?
Does Dr. Weinstein receive payments from pharmaceutical companies?
How do Dr. Weinstein's costs compare to other urology physicians in Palm Springs?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology